University of York
Research identifies potential new use for cancer treatment
Published in Law and Health Weekly, April 3rd, 2010
Anti-angiogenic drugs are used to try and prevent cancers from stimulating the growth of the blood vessels they need to survive and grow.
New research by the Centre for Immunology and Infection at the University of York suggests the same drugs may help in the treatment of other diseases including visceral leishmaniasis which kills 70,000 people worldwide every year.
The findings, published online today by the Journal of Clinical Investigation, show that anti-angiogenic drugs can improve the structure...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- (Cover the Uninsured, Facts and
National Medical Association - Will Status Quo Persist in Health Care? - 1105 Government Information Group
GovSec Announces Homeland Security Finance Forum Speakers - AARP Idaho
Gov. Signs Law Putting Politics Before Patients - AARP Idaho
Idaho Passes Bill to Put 'Conscience' Between Patients & End of Life Rights - Acacia Research Corporation
Acacia Subsidiary Licenses Medical Monitoring Technology to Draeger Medical - Acacia Research Corporation
Acacia Subsidiary Licenses Medical Picture Archiving and Communication System PACS Technology to Carestream Health - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
